
Behnam N. Tehrani
Interventional Cardiology | Cardiology
3580 Joseph Siewick Dr
401
Fairfax, VA 22033
401
Fairfax, VA 22033
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 75 publications
Paclitaxel-Coated Balloon Versus Uncoated Balloon for Coronary In-Stent Restenosis: Two-Year Follow-Up of the AGENT-IDE Randomized Clinical Trial.
Journal: Circulation
Published: July 06, 2026
Systems of Care in Cardiogenic Shock: Team-Based Management, Shock Networks, and Post Discharge Pathways.
Journal: Interventional cardiology clinics
Published: May 28, 2026
Paclitaxel-Coated Balloon for Treating In-Stent Restenosis in Racial and Ethnic Minority Patients: A Subanalysis From the AGENT IDE Trial.
Journal: Journal of the American Heart Association
Published: January 19, 2026
Editorial: Revascularization of chronic total occlusions following acute coronary syndromes: Is time of the essence or better late than never?
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: December 11, 2025
Towards an understanding of best practice: The good, the bad and the future of cardiogenic shock teams.
Journal: American heart journal
Published: November 17, 2025
Impact of standardized team-based care on cardiogenic shock outcomes over time.
Journal: ESC heart failure
Published: July 29, 2025
Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Occlusion in Older Adults.
Journal: JACC. Advances
Published: May 13, 2025
Intravascular Lithotripsy Versus Rotational Atherectomy in the Management of Calcific Coronary Lesions: A Systematic Review and Meta-Analysis.
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: May 13, 2025
Outcomes of Drug-Coated Balloon Versus Drug-Eluting Stent for In-Stent Restenosis and De-Novo Lesions: A Meta-Analysis of Randomized Controlled Trials.
Journal: Health science reports
Published: May 03, 2025
Short-Term Outcomes of Impella-Supported High-Risk Percutaneous Coronary Intervention in Surgically Ineligible Patients: Insights From PROTECT III.
Journal: Journal of the Society for Cardiovascular Angiography & Interventions
Published: April 09, 2025
Last Updated: 09/26/2026